FORBES J M & CO LLP

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1067532 Boston, MA

Position in DNA

as of Mar 31, 2026 · filed Apr 16, 2026 Compact

Position Value

$6,304,036

-$2,342,028 QoQ

Shares Held

1,028,391

-1.2% QoQ

Ownership

1.57%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FORBES J M & CO LLP holds $7,386,156 across 3 Biotechnology names. DNA ranks #1 (85.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DNA	Ginkgo Bioworks Holdings, Inc. This page	1,028,391	$6,304,036
2	AXSM	Axsome Therapeutics, Inc.	3,704	$626,050
3	NVCT	Nuvectis Pharma, Inc.	59,000	$456,070

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,304,036	1,028,391	-1.2%	Shares	Sole	2026-04-16
2025-12-31	$8,646,064	1,040,441	-1.9%	Shares	Sole	2026-01-21
2025-09-30	$15,459,771	1,060,341	-1.6%	Shares	Sole	2025-10-28
2025-06-30	$12,118,961	1,077,241	-1.6%	Shares	Sole	2025-07-18
2025-03-31	$6,239,014	1,094,564	+56.0%	Shares	Sole	2025-05-06
2024-12-31	$6,891,008	701,732	+461.4%	Shares	Sole	2025-01-28
2024-09-30	$1,018,750	125,000	—	Shares	Sole	2024-10-24
No filing history on record for this holder in this stock.